Re-Imagining Protein A Capture With Membrane Chromatography for Faster mAb Processing

Traditional resin chromatography has some significant limitations that slow down mAb purification. In this webinar, scientists from Altruist Biologics will discuss how switching to membranes could solve efficiency and cost challenges in downstream processes.

What You Will Learn:

Learn about the current challenges of Protein A packed-bed chromatography 
Discover how Altruist Biologics used Sartobind^® Rapid A to address capture bottlenecks 
Explore the outcomes of performance and cost evaluations of membrane chromatography

Clear form data

Consult Our Experts

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Register

Sun Chau Siu, PhD, MBA

Executive Director, Head of Technical Operations, Altruist Biologics

Dr Siu is Head of Technology at Altruist Biologics, a leading CDMO serving clients globally, and provides technical leadership in project development and innovation strategy. He has over 24 years of global biopharmaceutical experience and has held positions of increasing responsibilities in CMC strategy, process development, regulatory, MSAT, and GMP manufacturing. Before joining Altruist, Dr Sui worked at Genentech (United States), Roche (Singapore), Pfizer (UK), and Sanofi Pasteur (Canada). He holds a Ph.D. and MSc in Biochemical Engineering from University College London, UK, and a BSc (Hons) in Biochemistry and Chemistry from The University of British Columbia, Canada. He also obtained an executive MBA from Rutgers University, USA, and is a certified Project Management Professional (PMP). 

Yitao Feng, PhD

Head of Technology Innovation

Dr Feng is Head of Technology Innovation at Altruist Biologics, where he provides technical leadership in project execution as well as technical support in business development. He has been working in the biopharmaceutical industry for around 10 years. Before joining Altruist, Dr Feng worked in Innovent Biologics, supporting and/or leading process development and process characterization for over 20 projects, NDA filing for projects, and PAC for 3 projects. He holds a Ph.D. from the Hong Kong University of Science and Technology (HKUST) and a BSc from the University of Science and Technology of China (USTC). 